このページの翻訳は実験的なもので、現在開発中です。お待ちしております！

Nuheara 過去の業績

過去基準チェック /06

Nuhearaの収益は年間平均-11.8%の割合で減少していますが、 Tech業界の収益は年間増加しています。収益は年間11.4% 4.3%割合で増加しています。

主要情報

-11.8%

収益成長率

13.0%

EPS成長率

Tech 業界の成長	11.8%
収益成長率	4.3%
株主資本利益率	-246.9%
ネット・マージン	-653.3%
前回の決算情報	30 Jun 2023

Recent updates

収支内訳

Nuheara の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。

収益と収入の歴史

ASX:NUH 収益、費用、利益 ( )AUD Millions
日付	収益	収益	G+A経費	研究開発費
30 Jun 23	2	-13	7	4
31 Mar 23	2	-13	8	5
31 Dec 22	2	-14	8	6
30 Sep 22	3	-14	10	6
30 Jun 22	4	-15	11	6
31 Mar 22	5	-15	11	7
31 Dec 21	7	-14	11	7
30 Sep 21	9	-11	11	7
30 Jun 21	11	-8	10	6
31 Mar 21	9	-7	11	3
31 Dec 20	7	-7	11	2
30 Sep 20	5	-9	11	3
30 Jun 20	2	-12	11	3
31 Mar 20	2	-12	11	3
31 Dec 19	2	-12	11	3
30 Sep 19	2	-11	11	2
30 Jun 19	2	-10	11	2
31 Mar 19	3	-9	11	1
31 Dec 18	3	-7	10	0
30 Sep 18	4	-7	9	0
30 Jun 18	4	-7	9	0
31 Mar 18	4	-7	8	0
31 Dec 17	4	-7	7	1
30 Sep 17	3	-6	6	0
30 Jun 17	2	-5	4	0
31 Dec 16	0	-8	2	1
30 Sep 16	0	-8	2	1
30 Jun 16	0	-7	1	1

質の高い収益: NUHは現在利益が出ていません。

利益率の向上: NUHは現在利益が出ていません。

フリー・キャッシュフローと収益の比較

過去の収益成長分析

収益動向: NUHは利益が出ておらず、過去 5 年間で損失は年間11.8%の割合で増加しています。

成長の加速: NUHの過去 1 年間の収益成長を 5 年間の平均と比較することはできません。現在は利益が出ていないためです。

収益対業界: NUHは利益が出ていないため、過去 1 年間の収益成長をTech業界 ( 6.4% ) と比較することは困難です。

株主資本利益率

高いROE: NUHは現在利益が出ていないため、自己資本利益率 ( -246.93% ) はマイナスです。

Nuheara 過去の業績

過去 基準チェック /06

主要情報

最近の業績更新

Full year 2023 earnings released: AU$0.084 loss per share (vs AU$0.16 loss in FY 2022)

First half 2023 earnings released: AU$0.048 loss per share (vs AU$0.065 loss in 1H 2022)

Nuheara Limited to Report Q1, 2023 Results on Oct 31, 2022

Full year 2022 earnings released: AU$0.16 loss per share (vs AU$0.10 loss in FY 2021)

Full year 2022 earnings released: AU$0.15 loss per share (vs AU$0.093 loss in FY 2021)

Nuheara Limited to Report Q2, 2022 Results on Jan 31, 2022

Recent updates

Nuheara Limited has completed a Follow-on Equity Offering in the amount of AUD 1.850332 million.

Nuheara Limited Announces the Retirement of David Cannington as Non-Executive Director

Nuheara Limited has completed a Follow-on Equity Offering in the amount of AUD 3.929624 million.

New major risk - Shareholder dilution

Does Nuheara (ASX:NUH) Have A Healthy Balance Sheet?

Full year 2023 earnings released: AU$0.084 loss per share (vs AU$0.16 loss in FY 2022)

Nuheara Limited, Annual General Meeting, Nov 22, 2023

New major risk - Financial position

Nuheara Limited Announces Appointment of Catherine Morgan as Head of Compliance, Regulatory and Legal

New minor risk - Share price stability

Nuheara Limited has completed a Follow-on Equity Offering in the amount of AUD 4.4 million.

First half 2023 earnings released: AU$0.048 loss per share (vs AU$0.065 loss in 1H 2022)

Insufficient new directors

Nuheara Announces Commercial Availability of HP Hearing PRO OTC Hearing Aid

Nuheara Limited has completed a Follow-on Equity Offering in the amount of AUD 3.025401 million.

Nuheara Limited Receives US FDA Approval and Launches HP Hearing PRO

Nuheara Limited to Report Q1, 2023 Results on Oct 31, 2022

Nuheara Limited Announces the Resignation of Jean-Marie Rudd as CFO

Full year 2022 earnings released: AU$0.16 loss per share (vs AU$0.10 loss in FY 2021)

Nuheara Limited, Annual General Meeting, Nov 29, 2022

Full year 2022 earnings released: AU$0.15 loss per share (vs AU$0.093 loss in FY 2021)

Nuheara Limited Welcomes US Food and Drug Administration's Final Ruling, Establishing A Regulatory Category for Over-The-Counter (Otc) Hearing Aids in the United States

Here's Why Nuheara (ASX:NUH) Must Use Its Cash Wisely

Nuheara Limited Announces Executive Changes

Nuheara Limited has filed an IPO in the amount of AUD 5 million.

Here's Why Nuheara (ASX:NUH) Must Use Its Cash Wisely

Nuheara Submits 510(k) for U.S. FDA Clearance

Nuheara Announces Executive Changes

Nuheara Limited Announces Successful Clinical Trial Self-Fitted Hearing Aids

Nuheara Limited to Report Q2, 2022 Results on Jan 31, 2022

Nuheara Clinical Trial and FDA 510(K) Pathway Update

We Think Nuheara (ASX:NUH) Needs To Drive Business Growth Carefully

Nuheara Limited Provides Update on Clinical Trial and Pathway to FDA 510(K) Approval

Is Nuheara (ASX:NUH) In A Good Position To Deliver On Growth Plans?

Full year 2021 earnings released: AU$0.005 loss per share (vs AU$0.011 loss in FY 2020)

Nuheara Limited Receives U.S. FDA Registration and Hearing Aid Device Listing

First half 2021 earnings released: AU$0.001 loss per share (vs AU$0.006 loss in 1H 2020)

What Can We Make Of Nuheara's (ASX:NUH) CEO Compensation?

Nuheara Limited has completed a Follow-on Equity Offering in the amount of AUD 11.5 million.

Nuheara Limited announced that it expects to receive AUD 11.5 million in funding

Nuheara Limited Appoints Warwick Sauer as Director

Is Nuheara (ASX:NUH) Using Debt In A Risky Way?

Nuheara Receives $2 Million Phase II Works with HP Inc

Full year earnings released - AU$0.011 loss per share

Nuheara Limited announced that it has received funding

収支内訳

収益と収入の歴史

フリー・キャッシュフローと収益の比較

過去の収益成長分析

株主資本利益率

総資産利益率

使用総資本利益率

過去の好業績企業の発掘

過去基準チェック /06